Two broad classification of research programs are: Qualitative and Quantitative. Today we will briefly discuss <<qualitative research programs>>.  Qualitative research is also known as surveys; the word qualitative means we are going to collect subjective data and not numbers. For example, if an individual is a smoker or non-smoker, the answer yes/ no will be…

Pharmacovigilance, or safety of a drug, involves collecting systematically, evaluation, observing, and avoidance of adverse reactions connected to therapies and medications. The field of pharmacovigilance is purely process-oriented and systematic in nature within the industry of pharmaceuticals. The experience of any unpleasant situation or any reactions arising in the body of a patient in response…

Drug safety entails safe use of medicinal products. This concept applies to over-the-counter as well as prescription medicines. It is also applicable for medical therapies indicated for certain disease conditions.  The governing principle for drug safety is indicated for making available products that are safe for use by patients and carry minimal risk of causing…

The consumption of therapeutic products is meant for a particular objective. Along with their effectiveness in the treatment of a specific illness, they should be safe for intake. The aspect of safety is not only for the available medications in the market but also for the developing medications and the ones in different developmental stages.…

Systematic exploration of novel treatments, interventions, or medications in humans are a part of the clinical trials for determination of their efficacy, safety, and probable side effects. The populace of clinical trials is comprised of adults belonging to a healthy population and also participants with underlying diseases for evaluation of the efficacy and safety of…

Children constitute a special population in society and any experimentation in this population must be considered judiciously. In drug development participation of children is considered under exceptional conditions such as the potential drug is specifically developed for the pediatric population and the particular disease is most common in children. The pediatric research programs are governed…

In reaction to the shifts in the environment, the regulatory structure for medications is fast altering. The pharmaceutical industry is becoming increasingly globalized, there is an increase in digital technology and internet use, along with the changes in the lifestyle and habits of the patient populations bringing in remarkable shifts in the communities. The rapid…

Clinical trials are tedious, time-consuming and require robust mechanisms for ensuring patient retention in the study. For patients, frequent visits to the study site results in loss of time, effort as well as sometimes absenteeism at work. These are few of the reasons that patients drop-out from the study resulting in study data with lower…

After understanding the blog on the definition of (DCTs) decentralized clinical trials, the present blog depicts the utility of the (DCTs) decentralized clinical trials and their consolidated benefits. There are several compelling reasons that have made DCTs popular, and the clinical trial industry is striving to adopt this advancing technology. DCTs help enhance the efficiency…

Clinical trials are one of the most critical and difficult parts of the drug development process. The outcome from the clinical trial determines the next steps of development. Thus, credibility of the data is dependent on the quality of study conduct and the quality of data collected as part of the planned research programs. The…